These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30657930)

  • 1. Clinical trial with unlicensed yellow fever vaccine in Japan.
    Ujiie M; Terada M; Kobayakawa M; Ohmagari N
    J Travel Med; 2019 Sep; 26(6):. PubMed ID: 30657930
    [No Abstract]   [Full Text] [Related]  

  • 2. Yellow fever revaccination guidelines change - a decision too feverish?
    Grobusch MP; Goorhuis A; Wieten RW; Verberk JD; Jonker EF; van Genderen PJ; Visser LG
    Clin Microbiol Infect; 2013 Oct; 19(10):885-6. PubMed ID: 23927031
    [No Abstract]   [Full Text] [Related]  

  • 3. Yellow fever vaccine: WHO position on the use of fractional doses – June 2017.
    Wkly Epidemiol Rec; 2017 Jun; 92(25):345-50. PubMed ID: 28643507
    [No Abstract]   [Full Text] [Related]  

  • 4. Fractional-Dose Yellow Fever Vaccination - Advancing the Evidence Base.
    Vannice K; Wilder-Smith A; Hombach J
    N Engl J Med; 2018 Aug; 379(7):603-605. PubMed ID: 29995585
    [No Abstract]   [Full Text] [Related]  

  • 5. Yellow Fever Vaccine Administration at Global TravEpiNet (GTEN) Clinics during a Period of Limited Vaccine Availability in the United States, 2017-2018.
    Walker AT; Gershman MD; Rao SR; LaRocque RC; Ryan ET;
    Am J Trop Med Hyg; 2021 Jan; 104(3):1079-1084. PubMed ID: 33534766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yellow fever in Brazil: Epidemiological aspects and implications for travelers.
    Chaves TDSS; Orduna T; Lepetic A; Macchi A; Verbanaz S; Risquez A; Perret C; Echazarreta S; Rodríguez-Morales AJ; Lloveras SC
    Travel Med Infect Dis; 2018; 23():1-3. PubMed ID: 29751132
    [No Abstract]   [Full Text] [Related]  

  • 7. Addressing a Yellow Fever Vaccine Shortage - United States, 2016-2017.
    Gershman MD; Angelo KM; Ritchey J; Greenberg DP; Muhammad RD; Brunette G; Cetron MS; Sotir MJ
    MMWR Morb Mortal Wkly Rep; 2017 May; 66(17):457-459. PubMed ID: 28472025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yellow Fever Vaccine for People Living With HIV Infection.
    Andrews L
    J Assoc Nurses AIDS Care; 2018; 29(2):345-347. PubMed ID: 29217414
    [No Abstract]   [Full Text] [Related]  

  • 9. Yellow Fever in Angola and Beyond--The Problem of Vaccine Supply and Demand.
    Barrett AD
    N Engl J Med; 2016 Jul; 375(4):301-3. PubMed ID: 27276108
    [No Abstract]   [Full Text] [Related]  

  • 10. Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015.
    Staples JE; Bocchini JA; Rubin L; Fischer M;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):647-50. PubMed ID: 26086636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is a dose of 17D vaccine in the current context of Yellow Fever enough?
    Estofolete CF; Nogueira ML
    Braz J Microbiol; 2018; 49(3):683-684. PubMed ID: 29588199
    [No Abstract]   [Full Text] [Related]  

  • 12. Yellow fever vaccine as a vehicle to better travel medicine.
    Spira A
    J Travel Med; 2005; 12(6):303-5. PubMed ID: 16343380
    [No Abstract]   [Full Text] [Related]  

  • 13. Yellow fever vaccine: worthy friend or stealthy foe?
    Seligman SJ; Casanova JL
    Expert Rev Vaccines; 2016 Jun; 15(6):681-91. PubMed ID: 27087465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for travellers during the yellow fever outbreaks in Brazil-2018.
    Fujita DM; da Silva Nali LH; Salvador FS; de Andrade Júnior HF
    J Travel Med; 2018 Jan; 25(1):. PubMed ID: 29635644
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-Term Protection After Fractional-Dose Yellow Fever Vaccination: Follow-up Study of a Randomized, Controlled, Noninferiority Trial.
    Roukens AHE; van Halem K; de Visser AW; Visser LG
    Ann Intern Med; 2018 Dec; 169(11):761-765. PubMed ID: 30476963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of vaccination against yellow fever of persons traveling to endemic areas].
    Dabrowska MM; Flisiak R
    Przegl Epidemiol; 2010; 64(2):319-22. PubMed ID: 20731245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linking yellow fever vaccinator approval and renewal with training in travel medicine in New Zealand.
    O'Brien B; Leggat PA
    Travel Med Infect Dis; 2010 Jul; 8(4):210-2. PubMed ID: 20970723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yellow fever vaccination for Chilean tourists visiting Brazil. Practical considerations.
    Weitzel T; Perret C; Valdivieso F; Abarca K; Vial P
    Rev Chilena Infectol; 2018; 35(5):587-590. PubMed ID: 30725008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractional dosing of yellow fever vaccine during shortages: perspective from Canada.
    Teitelbaum P; Bui YG; Libman M; McCarthy A
    J Travel Med; 2018 Jan; 25(1):. PubMed ID: 30346564
    [No Abstract]   [Full Text] [Related]  

  • 20. CDC Travelers’ Health Branch releases free, web-based training course Yellow Fever: Information for Health Care Professionals Advising Travelers.
    Sommers T; Gershman M
    Clin Infect Dis; 2011 Sep; 53(5):vi-vii. PubMed ID: 21969945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.